Agreement offers a seamless procurement model that gives network operators the benefits of network disaggregation without traditional procurement challenges
SANTA CLARA, Calif., March 8, 2021 – IP Infusion, a leading provider of network disaggregation solutions for telecom and data communications operators, today announced an agreement with KGPCo, a leading telecom distributor in North America, to be a strategic distribution partner to serve direct telecom customers. The agreement focuses on product support for its Disaggregated Cell Site Gateway (DCSG) and Universal Customer Premises Equipment (uCPE) networking solutions.
Working with IP Infusion as an authorized distribution partner, KGPCo will be providing bundled solutions for DCSG products with IP Infusion's OcNOS® and DANOS Vyatta-edition network operating systems, as well as uCPE solutions using DANOS-Vyatta edition.
"Together with KGPCo, we will be addressing the procurement pain points being experienced by telecommunications service providers by paving a seamless migration path to adopting a disaggregated networking model," said Atsushi Ogata, President and CEO of IP Infusion. "This agreement reinforces our commitment to ease the consumption demands for network disaggregation and to provide a one-stop shop for solutions and world-class 24/7 global support."
"KGPCo is committed to providing a world-class procurement experience that, together with IP Infusion, provides a seamless path to network disaggregation without the traditional procurement challenges," said Peter Wraight, EVP & CSO, KGPCo. "Our model of bundled solutions enables service providers to reduce their capital and operating expenditures while rapidly launching more services for their customers."
OcNOS is the industry's first full-featured modular extensible network OS for white box open networking solutions offering advanced capabilities that include extensive switching and routing support. DANOS-Vyatta edition is a production-ready, carrier grade, feature-rich network operating system (NOS) that is based on the DANOS open-source software.
About KGPCo
KGPCo is the premier product distribution and networks service provider to the telecommunications industry. KGPCo is the only company in the industry that offers a complete range of solutions for network management, engineering, implementation and integration services, cloud solutions, and a national advanced supply chain network. With our Solution Innovation Center and ecosystem of the top telecommunications and technology partners, KGPCo helps companies navigate today's challenges and implement tomorrow's innovations.
IP Infusion 소개
IP Infusion is a leading provider of open network software and solutions for carriers, service providers and data center operators with over 500 customers and thousands of deployments. Our solutions enable network operators to disaggregate their networks to accelerate innovation, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier grade robustness.
IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.
IP Infusion and OcNOS are trademarks or registered trademarks of IP Infusion. ACCESS is a registered trademark or trademark of ACCESS CO., LTD. in the United States, Japan and/or other countries. Northforge Innovations is a registered trademark of Northforge Innovations, Inc. All other trademarks, service marks, registered trademarks, or registered service marks mentioned are the property of their respective owners.
-end-
미디어 문의
Katherine Verducci, 1903 PR, kverducci@1903pr.com, 408.429.5779
IP Infusion 소개
IP Infusion은 오픈 네트워킹 소프트웨어의 선도적 공급업체로서, 서비스 프로바이더, 데이터센터, AI 패브릭 네트워크를 위한 캐리어급 네트워크 운영체제인 OcNOS를 제공합니다. 26+ 년의 네트워킹 전문성과 전 세계 600+ 오퍼레이터 실적을 바탕으로, Edgecore Networks, UfiSpace, Celestica 등 파트너의 검증된 오픈 하드웨어에서 개방적이고 멀티벤더이며 비용 효율적이고 유연한 네트워크 인프라를 구현합니다. IP Infusion은 ACCESS CO., LTD.(도쿄증권거래소: 4813)의 완전 자회사입니다.
미디어 문의
For press inquiries, analyst briefings, or media materials, please 팀에 문의 or email pr@ipinfusion.com.
미래예측 진술
본 보도자료에는 IP Infusion의 제품, 기술 및 계획에 관한 미래예측 진술이 포함될 수 있습니다. 미래예측 진술은 공개일 현재 이용 가능한 정보에 기초하며 위험과 불확실성을 수반합니다. 실제 결과는 다를 수 있습니다. 제품 계획, 기능, 출시 시기 및 제공 여부는 예고 없이 변경될 수 있으며 약정, 약속 또는 법적 의무를 구성하지 않습니다. IP Infusion은 미래예측 진술을 갱신할 의무를 지지 않습니다.